Condition
Advanced Biliary Tract Cancer clinical trials and research
Research outlook What's coming for Cholangiocarcinoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 5 Advanced Biliary Tract Cancer clinical trials that are recruiting, at sites in 2 countries (most in China (4), United States (1)). By phase: Phase 3 (2), Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Advanced Biliary Tract Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Select a dose and test nanvuranlat versus physician's best choice for adults with biliary tract cancer | Phase 3 | Duarte, California and 17 other locations | Recruiting | Dec 5, 2025 |
| SHR-8068 with adebrelimab and platinum chemotherapy versus durvalumab with platinum chemotherapy for first-line advanced biliary tract cancer | Phase 3 | Hangzhou, Zhejiang | Recruiting | Nov 17, 2025 |
| Combining GemCis with PD-1/PD-L1 inhibitors for advanced biliary tract cancer | — | Shanghai, Shanghai Municipality | Recruiting | May 25, 2025 |
| BL-B01D1 plus a PD-1/PD-L1 antibody for advanced biliary tract cancer | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | May 18, 2025 |
| Combining Surufatinib with Gemcitabine, Cisplatin, and Durvalumab/Pembrolizumab for Advanced Biliary Tract Cancer | Phase 2 | Beijing, Beijing Municipality | Recruiting | Nov 27, 2024 |
All recruiting trials (5)
-
Select a dose and test nanvuranlat versus physician's best choice for adults with biliary tract cancer
This trial will test whether nanvuranlat helps adults with advanced biliary tract cancer live longer or control their disease better than a doctor's chosen chemotherapy (FOLFOX or FOLFIRI) or best supportive care after one prior standard therapy.
-
SHR-8068 with adebrelimab and platinum chemotherapy versus durvalumab with platinum chemotherapy for first-line advanced biliary tract cancer
This trial tests whether SHR-8068 plus adebrelimab and platinum chemotherapy works better than durvalumab plus platinum chemotherapy as first treatment for people with advanced biliary tract cancer.
-
Combining GemCis with PD-1/PD-L1 inhibitors for advanced biliary tract cancer
This study is testing if combining a chemotherapy treatment with immune therapy can help people with advanced biliary tract cancer feel better and live longer.
-
BL-B01D1 plus a PD-1/PD-L1 antibody for advanced biliary tract cancer
The treatment combines BL-B01D1 with a PD-1/PD-L1 antibody to see if it helps people with advanced biliary tract cancer.
-
Combining Surufatinib with Gemcitabine, Cisplatin, and Durvalumab/Pembrolizumab for Advanced Biliary Tract Cancer
This study is testing if adding a new drug called surufatinib to the standard treatment for advanced biliary tract cancer can help patients live longer and feel better.
Related topics
Quick answers
How many Advanced Biliary Tract Cancer clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (4 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.